These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6813486)
1. The problems of studying disease-remittive agents in RA. Huskisson EC J Rheumatol Suppl; 1982; 8():201-6. PubMed ID: 6813486 [TBL] [Abstract][Full Text] [Related]
2. Auranofin. Davis P Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485 [TBL] [Abstract][Full Text] [Related]
4. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711 [TBL] [Abstract][Full Text] [Related]
6. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483 [TBL] [Abstract][Full Text] [Related]
7. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation. Manthorpe R; Hørbov S; Sylvest J; Vinterberg H Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505 [TBL] [Abstract][Full Text] [Related]
8. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs. Harth M; Keown PA; Orange J J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447 [TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481 [TBL] [Abstract][Full Text] [Related]
10. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis. Hochberg MC Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712 [TBL] [Abstract][Full Text] [Related]
11. An analysis of worldwide safety experience with auranofin. Heuer MA; Pietrusko RG; Morris RW; Scheffler BJ J Rheumatol; 1985 Aug; 12(4):695-9. PubMed ID: 3932651 [TBL] [Abstract][Full Text] [Related]
12. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose. Bernhard GC J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477 [TBL] [Abstract][Full Text] [Related]
13. Auranofin: 1 mg or 9 mg? The search for the appropriate dose. Calin A; Saunders D; Bennett R; Jacox R; Kaplan D; O'Brien W; Paulus HE; Roth S; Weiss T J Rheumatol Suppl; 1982; 8():146-8. PubMed ID: 6813476 [No Abstract] [Full Text] [Related]
14. Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities. van Riel PL; Gribnau FW; van de Putte LB; Yap SH J Rheumatol; 1983 Apr; 10(2):222-6. PubMed ID: 6408256 [TBL] [Abstract][Full Text] [Related]
15. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin. Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482 [TBL] [Abstract][Full Text] [Related]